RAPT Therapeutics Inc.

NASDAQ: RAPT · Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT

RAPT Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.64M -17.16M -53.25M -18.43M -27.66M -30.52M -30.88M -31.37M -25.28M -29.27M -22.95M -21.23M -19.18M -20.47M -17.93M -18.65M -16.11M -16.51M
Depreciation & Amortization
228K 252K 287K 297K 305K 314K 323K 325K 269K 299K 252K 260K 274K 261K 231K 229K 256K 280K
Stock-Based Compensation
4.54M 4.65M 4.59M 4.56M 5.38M 5.4M 4.43M 4.33M 4.24M 4.09M 3.02M 2.87M 2.67M 2.7M 2.09M 2.29M 2.89M 2.69M
Other Working Capital
35.47M -35.47M 34.79M 311K 411K -1.15M -919K -564K -209K -144K -2.65M -358K -1.51M -532K -2.86M -51K -1.34M -981K
Other Non-Cash Items
-38.43M -109K 54K 32K -164K 6.36M 4.51M 583K 584K -857K -265K 646K 1.14M 568K 407K 583K 282K 256K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -5.15M -1.56M -2.16M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
40.04M -40.04M 37.88M -4.08M -6.02M -1.88M -990K 5.81M -6.46M 7.13M -2.91M 315K -99K 1.36M -5.48M 3.03M -1.23M -619K
Operating Cash Flow
-11.27M -52.41M -10.44M -17.62M -28.15M -27.08M -27.75M -21.88M -28.81M -18.6M -22.85M -17.15M -15.2M -15.58M -20.68M -12.52M -13.92M -13.91M
Capital Expenditures
-40K -43K -1K -17K 1K -105K -67K -66K -233K -759K -49K -81K -566K -149K -394K -70K -64K -227K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -20.71M -25.82M -32.67M -26.07M 41.22M 17.52M 9.89M n/a n/a n/a n/a n/a
Purchase of Investments
-48.89M -89.76M -30.8M -17.41M -17.19M -16.81M -55.26M -32.29M -36.07M -37.88M -78.14M -40.48M -66.19M -6.05M -16.93M -29.34M -102.97M -15.73M
Sales Maturities Of Investments
41.67M 32.74M 29.96M 35.87M 36.41M 32.81M 75.97M 58.1M 68.74M 63.95M 36.92M 22.96M 56.29M 30.04M 1.43M 15.24M 39.34M 28.37M
Other Investing Acitivies
n/a n/a n/a n/a n/a 15.99M 20.71M 25.82M 32.67M 26.07M -41.22M -17.52M -9.89M 23.99M -15.5M -14.1M -63.63M 12.64M
Investing Cash Flow
-7.26M -57.06M -843K 18.45M 19.21M 15.89M 20.64M 25.75M 32.44M 25.31M -41.27M -17.6M -10.46M 23.84M -15.89M -14.17M -63.69M 12.41M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 77K n/a 701K 67K 458K 106K 767K 116K 334K 272K 654K 132K 413K 472K 1.02M 121K
Financial Cash Flow
161K n/a 143.12M n/a 701K 9.04M 458K 106K 767K 116K 75.36M 5.25M 50.44M 132K 601K 472K 139.11M 1.3M
Net Cash Flow
-18.37M -109.48M 131.84M 823K -8.24M -2.16M -6.66M 3.97M 4.4M 6.82M 11.24M -29.5M 24.79M 8.39M -35.97M -26.22M 61.5M -198K
Free Cash Flow
-11.31M -52.46M -10.44M -17.64M -28.15M -27.19M -27.82M -21.95M -29.04M -19.36M -22.9M -17.23M -15.76M -15.73M -21.07M -12.59M -13.98M -14.14M